CS206891A3 - Derivatives of aminoacids, process of their preparation and pharmaceuticals being prepared therefrom - Google Patents

Derivatives of aminoacids, process of their preparation and pharmaceuticals being prepared therefrom

Info

Publication number
CS206891A3
CS206891A3 CS912068A CS206891A CS206891A3 CS 206891 A3 CS206891 A3 CS 206891A3 CS 912068 A CS912068 A CS 912068A CS 206891 A CS206891 A CS 206891A CS 206891 A3 CS206891 A3 CS 206891A3
Authority
CS
Czechoslovakia
Prior art keywords
aminoacids
pharmaceuticals
derivatives
preparation
prepared therefrom
Prior art date
Application number
CS912068A
Other languages
Czech (cs)
Inventor
Peter Dr Raddatz
Klaus-Otto Dr Minck
Claus J Dr Schmitges
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CS206891A3 publication Critical patent/CS206891A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS912068A 1990-07-05 1991-07-04 Derivatives of aminoacids, process of their preparation and pharmaceuticals being prepared therefrom CS206891A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4021512A DE4021512A1 (en) 1990-07-05 1990-07-05 AMINOSAEUREDERIVATE

Publications (1)

Publication Number Publication Date
CS206891A3 true CS206891A3 (en) 1992-01-15

Family

ID=6409762

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912068A CS206891A3 (en) 1990-07-05 1991-07-04 Derivatives of aminoacids, process of their preparation and pharmaceuticals being prepared therefrom

Country Status (11)

Country Link
EP (1) EP0464517A3 (en)
JP (1) JPH04305562A (en)
KR (1) KR920002626A (en)
AU (1) AU8021791A (en)
CA (1) CA2046112A1 (en)
CS (1) CS206891A3 (en)
DE (1) DE4021512A1 (en)
HU (1) HUT61321A (en)
IE (1) IE912343A1 (en)
PT (1) PT98223A (en)
ZA (1) ZA915243B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102187636B1 (en) * 2018-08-29 2020-12-07 (주)화인켐 A Composition for Paint Detackification Comprising Chitosan Ammonium Salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3717631A1 (en) * 1987-05-26 1988-12-15 Merck Patent Gmbh AMINO ACID DERIVATIVES
DE3825242A1 (en) * 1987-07-27 1989-02-09 Ciba Geigy Ag Histidinylamino compounds substituted by sulphur-containing groups

Also Published As

Publication number Publication date
EP0464517A3 (en) 1993-04-07
HU912282D0 (en) 1991-12-30
IE912343A1 (en) 1992-01-15
DE4021512A1 (en) 1992-01-16
KR920002626A (en) 1992-02-28
EP0464517A2 (en) 1992-01-08
JPH04305562A (en) 1992-10-28
PT98223A (en) 1992-05-29
HUT61321A (en) 1992-12-28
AU8021791A (en) 1992-01-09
CA2046112A1 (en) 1992-01-06
ZA915243B (en) 1992-04-29

Similar Documents

Publication Publication Date Title
CS189391A3 (en) Dialkoxypiridylbenzimidazole derivatives, process of their preparation and their pharmaceutical use
CS257491A3 (en) 3-amidopyrazole derivatives, process of their preparation and pharmaceutical compositions comprising them
HUT65903A (en) Oxamides, process for preparing them and pharmaceutical compositions containing them
CS44091A3 (en) 1-phenylimidazole derivative, process of its preparation and use
ZA914296B (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
CS331491A3 (en) Cyclopeptides, process of their preparation and pharmaceuticals based thereon
CS299991A3 (en) Derivatives of 2-aminopyrimidine-4-carboxamide, process of their preparation and their application as medicaments
CS202292A3 (en) Novel pyrrolopyrazines, process of their preparation and medicaments based thereon
HU9202864D0 (en) Gycinamide derivatives, their production and pharmaceutical preparatives containing them
CS316491A3 (en) Derivatives of amino acids, process of their preparation and pharmaceuticals based thereon
GB2240104B (en) New arylvinylamide derivatives and process for their preparation
IL105100A0 (en) Glutamic acid derivatives and process for their preparation
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
CS382891A3 (en) N-arylpiperizinealkaneamide derivatives, process of their preparation and pharmaceuticals based thereon
CS235091A3 (en) Novel derivatives of 1-diphenylmethylpiperazine, process of their preparation and their application as medicaments
LTIP760A (en) Novel thienothiazine derivatives, process for preparing thereof and pharmaceutical preparations
CZ78095A3 (en) Novel 17 beta-substituted derivatives of 4-azaandrostane, pharmaceutical preparations based thereon and process of their preparation
CS206891A3 (en) Derivatives of aminoacids, process of their preparation and pharmaceuticals being prepared therefrom
CS390991A3 (en) Thiadiazinone derivatives, process of their preparation andpharmaceuticals based thereon
HU8902302D0 (en) Process for preparation of 1,2-hydroxy-phosphonates and derivatives thereof
CS97892A3 (en) Adenosine derivatives, process of their preparation and therapeuticalcompositions comprising said derivatives
CS259991A3 (en) Amino acids derivatives, process of their preparation and pharmaceuticals prepared therefrom
CS377591A3 (en) Acid amides, process of their preparation and pharmaceutical compositionsbased thereon
ZA9335B (en) Difluoromethylenandrostenone derivatives and process for their preparation
GB2273096B (en) Piperido (4',3':16,17)-4-Aza-5alpha-androstan-3-one derivatives and process for their preparation